Dividend Kings: Still Worth the Crown?

Okay, let’s talk Dividend Kings. These aren’t actual monarchs, sadly. No tiny crowns or velvet robes. Just companies that have raised their dividends for 50+ years. Which, in the stock market, is basically an eternity. It’s like finding a pair of jeans that still fit from high school – rare, and you cling to it for dear life. They can be solid long-term investments, even when the market is doing its usual dramatic thing.

There are 57 of these dividend-doling dynasties, spanning every sector you can imagine. And honestly, sifting through them all feels a bit like speed dating. But three, right now, are flashing particularly promising signals. Not just for their consistent payouts, but because, let’s be real, they might actually go up in value. Which is always a plus.

We’re talking Genuine Parts (GPC 0.46%), Kimberly-Clark (KMB 0.65%), and Target (TGT +0.96%). Don’t worry, I’ll explain why I’m not completely losing it.

Genuine Parts: The Spinoff Saga (It’s Complicated)

Genuine Parts had a bit of a wobble recently, post-earnings. Like that moment when you realize your outfit doesn’t quite work for the party. Investors got spooked, even though management hinted at a potential game-changer: a spinoff. It’s a classic corporate move. Split up the company, unlock value, blah, blah, blah. It’s like rearranging the furniture to make the mess look less obvious.

The stock has stabilized around $115-$120, which feels like a reasonable entry point. They’re currently yielding 3.7%, which is decent. They’ve been raising payouts for 71 years. 71! That’s longer than most of us have been alive. Their plan is to split into two companies, one focused on automotive parts and the other on industrial parts. This makes sense, because other industrial distributors, like Fastenal, get a premium valuation. It’s basically saying, “Hey, we’re worth more apart than together!”

Kimberly-Clark: Mergers, Acquisitions, and Kleenex (Oh My!)

Speaking of strategic moves, Kimberly-Clark, the folks behind Huggies and Kleenex, is also playing corporate chess. They’re planning to acquire Kenvue, the former Johnson & Johnson consumer health division, in a $48.7 billion deal. It’s a big number, even for Wall Street. It’s like combining your favorite comfort foods – sometimes it works, sometimes it’s a disaster.

Kenvue owns brands like Tylenol and Band-Aid. Shareholders have approved the deal, which suggests they’ve put to rest concerns about potential Tylenol lawsuits. Management thinks they can find $2 billion in cost synergies. Which, let’s be honest, usually means layoffs. But hey, at least the stock price might go up. Currently, Kimberly-Clark yields 3.5%, and they’ve been growing their dividend by 3.8% annually. Solid, if not exactly thrilling.

Target: The Turnaround (Still in Progress)

Three months ago, everyone was writing Target’s obituary. Now, the stock is up a third. It’s like that friend who always bounces back from a terrible breakup. Investors initially weren’t thrilled with the turnaround efforts, but now they’re seeing some progress. The stock is around $120, but I still think there’s room to run.

Analysts are predicting 12.2% earnings growth this year. And Target is still trading at a significant discount to Walmart, which is trading at a ridiculous 43 times forward earnings. It’s like comparing a sensible sedan to a sports car. Target yields 3.9%, and they’ve been growing their dividend by 7.7% annually. Which, in this market, is nothing to sneeze at.

So, are these Dividend Kings still worth the crown? Maybe. It’s not a guaranteed home run, but they offer a combination of stability, growth potential, and a decent dividend yield. And honestly, in this market, that’s about as good as it gets.

2026-03-10 19:24

Genuine Parts: The Spinoff Saga (It’s Complicated)

Kimberly-Clark: Mergers, Acquisitions, and Kleenex (Oh My!)

Target: The Turnaround (Still in Progress)

Read More